Biodesix (BDSX) Non Operating Income (2019 - 2026)

Biodesix has reported Non Operating Income for 8 years, with the latest figure at -$1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 1724.49% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$7.0 million (up 31.93% YoY), and the FY2025 full-year result was -$7.4 million, up 12.34% from the prior year.
• Non Operating Income for Q1 2026 stood at -$1.6 million, up from -$2.0 million in the prior quarter.
• The five-year high for Non Operating Income was $98000.0 in Q1 2025, with the low at -$10.8 million in Q4 2023.
• Historically, Non Operating Income has averaged -$3.0 million across 5 years, with a median of -$2.0 million in 2025.
• Annual changes were most pronounced in 2024 — Non Operating Income slumped 83450.0% — and 2025, when it soared 103.78%.
• Biodesix's Non Operating Income stood at -$6.4 million in 2022, then plunged by 67.62% to -$10.8 million in 2023, then grew by 22.69% to -$8.4 million in 2024, then surged by 75.91% to -$2.0 million in 2025, then grew by 20.91% to -$1.6 million in 2026.
• The last three Non Operating Income figures came in at -$1.6 million (Q1 2026), -$2.0 million (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.